Initiative for Multipurpose Prevention Technologies (IMPT) 2017 Annual Report
2018 | See the interactive report.
In 2017, 214 million women around the world had an unmet need for contraception. Meanwhile, over 350 million new sexually transmitted infections (STIs) occur each year—and this number only includes the four most prevalent STIs: chlamydia, gonorrhea, syphilis and trichomoniasis. How can advocates and funders work together to address these intertwined public health crises?
Multipurpose prevention technologies (MPTs) are an innovative class of products that deliver varied combinations of HIV prevention, other STI prevention, and contraception. There are currently nearly a dozen MPTs in clinical trials, with many other innovative technologies in earlier stages of development, including longer acting vaginal rings, fast dissolving films and inserts, and innovative and effective gels.
Effective, affordable, and widely available MPTs would save lives and improve the health of women and their families across the globe. The Initiative for Multipurpose Prevention Technologies (IMPT), a project of PHI's CAMI Health, advances the development of MPTs to address the interlinked risks of unintended pregnancy and STIs, including HIV. We believe that the availability of desirable methods that deliver an array of prevention combinations will improve the lives of women and their families worldwide.
Throughout 2017, MPTs were in the spotlight. From leading organizations like the National Institutes of Health and the World Health Organization prioritizing MPTs in their strategies; to a growing understanding of future MPT end-users; to MPTs highlighted at conferences, in peer-reviewed publications, as well as in the popular press. The energy in the MPT field feels unprecedented—momentum that the IMPT aim to accelerate in 2018.
Learn more in the Initiative for Multipurpose Prevention Technologies (IMPT) 2017 interactive Annual Report. Get a snapshot of the year's highlights, including the expansion of Secretariat communications and advocacy efforts and the continued growth of the MPT field.